KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Operating Expenses (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Operating Expenses for 17 consecutive years, with -$3.5 billion as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 3.64% to -$3.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.0 billion through Dec 2025, down 3.73% year-over-year, with the annual reading at $24.0 billion for FY2025, 3.73% down from the prior year.
  • Operating Expenses hit -$3.5 billion in Q4 2025 for Johnson & Johnson, down from $9.7 billion in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $10.5 billion in Q1 2021 to a low of -$16.7 billion in Q1 2022.
  • Historically, Operating Expenses has averaged $6.7 billion across 5 years, with a median of $9.1 billion in 2024.
  • Biggest five-year swings in Operating Expenses: crashed 258.36% in 2022 and later surged 143.61% in 2023.
  • Year by year, Operating Expenses stood at $9.5 billion in 2021, then dropped by 10.09% to $8.5 billion in 2022, then rose by 21.36% to $10.3 billion in 2023, then tumbled by 134.78% to -$3.6 billion in 2024, then grew by 3.64% to -$3.5 billion in 2025.
  • Business Quant data shows Operating Expenses for JNJ at -$3.5 billion in Q4 2025, $9.7 billion in Q3 2025, and $9.5 billion in Q2 2025.